Orchestra BioMed Holdings, Inc. (NasdaqGM: OBIO)
Health Care · Health Care Equipment & Supplies · US
$5.87
-1.34% today · +86.5% 1Y
Orchestra BioMed Holdings, Inc. (NasdaqGM: OBIO) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $357.63M and employs 86 people.
Over the last twelve months the share price has gained 86.5%, trading between 2.86 and 6.50.
Tweenvest scores Orchestra BioMed Holdings, Inc. across four factors: quality 46/100, value 87/100. Its strongest factor is value.
OBIO price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $357.63M
- Revenue (TTM)
- $31.98M
- P/E
- —
- EPS
- -1.00
- Dividend yield
- —
- Beta (5Y)
- 0.52
- 52-week high
- $6.50
- 52-week low
- $2.86
- Avg volume (3M)
- —
- Shares outstanding
- 60.11M
- Employees
- 86
- Next earnings
- —
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. operates as an innovative company in the biomedical sector. Its leading product candidates are BackBeat Cardiac Neuromodulation Therapy (CNT), designed to manage hypertension, and the Virtue Sirolimus AngioInfusion Balloon (SAB), aimed at treating atherosclerotic artery disease. The company's offerings also encompass FreeHold retractors, which are solutions for minimally invasive surgical procedures. Orchestra BioMed has formed key alliances to advance its products: a strategic collaboration with Medtronic focuses on developing and commercializing BackBeat CNT for pacemaker-indicated patients suffering from hypertension. Additionally, a partnership with Terumo Corporation is dedicated to the development and market introduction of Virtue SAB for artery disease. The company's headquarters are located in New Hope, Pennsylvania.
- ISIN
- US68572M1062
- Founded
- 2018
- Listed since
- Aug 4, 2020
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jiangsu Skyray Instrument Co., Ltd.SZSE: 300165 | $368.41M | CN¥4.98 | -1.78% |
| Revenio Group OyjHLSE: REG1V | $361.56M | €11.20 | +0.90% |
| IVF Hartmann Holding AGSWX: VBSN | $359.72M | CHF126.00 | +0.40% |
| Kontour (Xi'an) Medical Technology Co., Ltd.SHSE: 688314 | $357.68M | CN¥29.35 | -2.81% |
| Carvolix SAENXTPA: CVX | $356.88M | €5.30 | -1.49% |
| Kitazato CorporationTSE: 368A | $356.70M | ¥1,412.00 | +3.29% |
| i-SENS, Inc.KOSDAQ: A099190 | $354.65M | ₩16,580.00 | -1.25% |
| Maider Medical Industry Equipment Co. Ltd.SHSE: 688310 | $353.01M | CN¥14.62 | -3.94% |
Figures last refreshed Oct 11, 2026.